GoodRx Holdings Inc - Ordinary Shares - Class A

GoodRx Holdings Target Price

Analysts' average 12-month price target for GoodRx Holdings is $4.2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.34

Average Target Price

$4.19

25.4% upside

4 analysts in the last 4 months

High: $5 | Low: $3.75

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-20	Barclays	$4	19.8% upside
2026-08-13	UBS	$3.75	12.3% upside
2026-08-07	Goldman Sachs	$4	19.8% upside
2026-08-06	Leerink Partners	$5	49.7% upside
2026-05-08	Goldman SachsEric Sheridan	$3.5	4.8% upside
2026-02-26	Leerink PartnersMichael Cherny	$3	10.2% downside
2026-01-22	JefferiesGlen Santangelo	$2.75	17.7% downside
2025-12-18	Morgan Stanley	$4	19.8% upside
2025-12-08	Barclays	$3	10.2% downside
2025-08-11	Deutsche BankGeorge Hill	$6	79.6% upside
2024-06-10	Morgan StanleyCraig Hettenbach	$9.5	184.4% upside
2024-05-23	RBC CapitalMark Mahaney	$10	199.4% upside
2024-05-16	BarclaysStephanie Davis	$9	169.5% upside
2024-05-16	Raymond JamesAaron Kessler	$10	199.4% upside
2024-04-10	BOCOM International Holdings CompanyScott Schoenhaus	$9	169.5% upside
2024-04-10	KeyBancScott Schoenhaus	$9	169.5% upside
2024-03-25	Wells FargoStan Berenshteyn	$10	199.4% upside
2023-11-13	Goldman SachsEric Sheridan	$3	10.2% downside
2022-12-01	Citigroup	$7	109.6% upside
2022-08-09	BarclaysSteve Valiquette	$13	289.2% upside
2022-06-07	Robert W. BairdVikram Kesavabhotla	$7	109.6% upside
2022-05-12	Wells FargoStan Berenshteyn	$9	169.5% upside
2022-03-01	J.P. MorganDoug Anmuth	$20	498.8% upside
2022-03-01	Cowen & Co.Charles Rhyee	$22	558.7% upside
2022-03-01	Goldman SachsEric Sheridan	$30	798.2% upside
2022-03-01	Deutsche BankGeorge Hill	$20	498.8% upside
2022-03-01	Bank of America SecuritiesJustin Post	$28	738.3% upside
2021-12-21	StephensScott Schoenhaus	$45	1247.3% upside
2021-05-14	CitigroupNicholas Jones CFA	$53	1486.8% upside

GoodRx Holdings (GDRX) FAQ

GoodRx Holdings (GDRX) currently reports a target price of $4.2. Use the charts on this page to explore GoodRx Holdings's target price history and peer comparisons.

Analysts' average 12-month price target for GoodRx Holdings is $4.2, about 25.4% upside from the current share price of $3.34. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $4.2, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GoodRx Holdings, and consider following GDRX for alerts when major investors trade the stock.

GoodRx Holdings is classified in the Technology sector. On target price, it currently shows $4.2. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing GDRX with unrelated industries.